Search
-
HIV analyst call presentation
Media
https://www.gsk.com/media/3505/hiv-analyst-call-presentation.pdf
First published: 26 February 2017
-
Annual Summary 2015
Media
https://www.gsk.com/media/1492/annual-summary-2015.pdf
First published: 13 June 2017
-
GSK statement of apology
Media
https://www.gsk.com/media/1652/gsk-statement-of-apology.pdf
First published: 27 February 2017
-
Compulsory licences policy
Media
https://www.gsk.com/media/2931/compulsory-licences-policy.pdf
First published: 27 February 2017
-
Disclosure Patient Advocacy_Norway_2021
Media
https://www.gsk.com/media/7570/disclosure-patient-advocacy_norway_2021.pdf
First published: 30 March 2022
-
Health for all factsheet
Media
https://www.gsk.com/media/2744/health-for-all-factsheet.pdf
First published: 13 June 2017
-
Norway patient organisation funding disclosure 2022
Media
https://www.gsk.com/media/10110/norway-patient-organisation-funding-disclosure-2022.pdf
First published: 10 May 2023
-
Norway patient organisation disclosure 2022
Media
https://www.gsk.com/media/10097/norway-patient-organisation-disclosure-2022.pdf
First published: 13 June 2023
-
Dapro_26June
Media
https://www.gsk.com/media/10340/press-release-gsk-receives-positive-chmp-op.pdf
First published: 26 June 2023
-
Press Release Japan Accepts Arexvy Regulatory Application To Prevent RSV Disease In Adults Aged 50 59
Media
https://www.gsk.com/media/10736/press-release-japan-accepts-arexvy-regulatory-application-to-prevent-rsv-disease-in-adults-aged-50-59.pdf
First published: 12 December 2023